Background: Human Papillomavirus (HPV) is a common sexually
transmitted virus that is the primary cause of cervical cancer. Most
cervical cancer cases are caused by HPV strains that we currently have
a vaccine against. In May 2018, the Director-General of the World
Health Organization (WHO) announced a global call to action towards
the elimination of cervical cancer.
Objective: To assess the progression of HPV vaccination rates in the United States (U.S.) among different demographics and compare vaccination rates to cervical cancer rates in the U.S. since the WHO’s 2018 call to action.
Methods: In this statistical analysis, HPV vaccination and cervical cancer rates were evaluated in terms of demographics and location by state and urbanicity. Vaccination rates were obtained from TeenVaxView on the Centers for Disease Control and Prevention (CDC) website, and cervical cancer rates were obtained from the United States Cancer Statistics (USCS) Data Visualization tool on the CDC website.
Results: Average vaccination rates increased from 52.25% to 64% and cervical cancer rates have decreased from 7.54 to 6.67 per 100,000 people across all states from 2018 to 2022. Black and Hispanic populations had significantly higher vaccination rates compared to the White population between 2018-2022 across all states. Vaccination rates in metropolitan statistical area (MSA) principal cities was significantly higher than non-MSA locations.
Conclusion: Further recommendations or requirements for HPV vaccination could be effective in advancing HPV vaccination rates and reducing cervical cancer rates, with non-MSA locations and White populations as potential targets to increase vaccination.
Objective: To assess the progression of HPV vaccination rates in the United States (U.S.) among different demographics and compare vaccination rates to cervical cancer rates in the U.S. since the WHO’s 2018 call to action.
Methods: In this statistical analysis, HPV vaccination and cervical cancer rates were evaluated in terms of demographics and location by state and urbanicity. Vaccination rates were obtained from TeenVaxView on the Centers for Disease Control and Prevention (CDC) website, and cervical cancer rates were obtained from the United States Cancer Statistics (USCS) Data Visualization tool on the CDC website.
Results: Average vaccination rates increased from 52.25% to 64% and cervical cancer rates have decreased from 7.54 to 6.67 per 100,000 people across all states from 2018 to 2022. Black and Hispanic populations had significantly higher vaccination rates compared to the White population between 2018-2022 across all states. Vaccination rates in metropolitan statistical area (MSA) principal cities was significantly higher than non-MSA locations.
Conclusion: Further recommendations or requirements for HPV vaccination could be effective in advancing HPV vaccination rates and reducing cervical cancer rates, with non-MSA locations and White populations as potential targets to increase vaccination.